QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
British Columbia, |
||
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
|
||
(Address of principal executive offices) |
(Zip Code) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
TABLE OF CONTENTS
Page No. | ||||||
PART I. FINANCIAL INFORMATION | ||||||
Item 1. | 4 | |||||
Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 |
4 | |||||
5 | ||||||
6 | ||||||
7 | ||||||
Notes to the Condensed Consolidated Financial Statements (Unaudited) |
8 | |||||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
37 | ||||
Item 3. | 49 | |||||
Item 4. | 49 | |||||
PART II. OTHER INFORMATION | 50 | |||||
Item 1. | 50 | |||||
Item 1A. | 52 | |||||
Item 2. | 52 | |||||
Item 3. | 52 | |||||
Item 4. | 52 | |||||
Item 5. | 52 | |||||
Item 6. | 52 | |||||
53 |
2
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA
This Quarterly Report on Form10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “believe,” “will,” “expect,” “anticipate,” “estimate,” “intend,” “plan” and “would.” For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our common shares and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statements.
Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout our most recent Annual Report on Form 10-K and any updates described in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K as may be amended, supplemented or superseded from time to time by other reports we file with the U.S. Securities and Exchange Commission (the “SEC”). You should read this Quarterly Report on Form10-Q and the documents that we referenced herein and have filed as exhibits to the reports we file with the SEC, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this Quarterly Report on Form 10-Q is accurate as of the date hereof. Because the risk factors in our SEC reports could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this Quarterly Report on Form 10-Q, and particularly our forward-looking statements, by these cautionary statements.
3
ITEM 1. |
FINANCIAL STATEMENTS |
September 30, |
December 31, |
|||||||
2022 |
2021 |
|||||||
(Revised) |
||||||||
Assets |
||||||||
Cash |
$ | $ | ||||||
Restricted cash |
||||||||
Accounts receivable, net of allowance for doubtful accounts of $ |
||||||||
Prepaid expenses |
||||||||
Inventories, net |
||||||||
Other current assets |
||||||||
Current Assets |
||||||||
Investments |
||||||||
Property, plant and equipment, net |
||||||||
Right-of-use |
||||||||
Other long-term assets |
||||||||
Intangible assets, net |
||||||||
Total Assets |
$ |
$ |
||||||
Liabilities and Shareholder’s Equity (Deficit) |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued and other current liabilities |
||||||||
Current portion of long-term debt, net of issuance costs |
||||||||
Derivative liabilities |
||||||||
Current portion of lease liabilities |
||||||||
Current Liabilities |
||||||||
Long-term debt, net of issuance costs |
||||||||
Deferred income tax |
||||||||
Long-term portion of lease liabilities |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies |
||||||||
Shareholders’ Equity (Deficit) |
||||||||
Common shares — |
||||||||
Shares to be issued |
||||||||
Additional paid-in capital (Refer to Note 6) |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Shareholders’ Equity (Deficit) |
$ |
$ |
( |
) | ||||
Total Liabilities and Shareholders’ Equity (Deficit) |
$ |
$ |
||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Revenues, net of discounts |
$ |
$ |
$ |
$ |
||||||||||||
Costs and expenses applicable to revenues |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses |
||||||||||||||||
Selling, general and administrative expenses |
||||||||||||||||
Depreciation and amortization |
||||||||||||||||
(Recoveries), write-downs and other charges, net |
( |
) |
( |
) |
||||||||||||
Impairment loss |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Interest income |
||||||||||||||||
Other income |
||||||||||||||||
Interest expense |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Accretion expense |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Provision for debt obligation fee |
( |
) |
( |
) |
( |
) | ||||||||||
Loss on debt extinguishment (Refer to Note 5) |
( |
) |
||||||||||||||
(Losses)/gains from changes in fair value of financial instruments |
( |
) |
( |
) |
( |
) |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Income tax expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
Weighted average number of common shares outstanding |
Three Months Ended September 30, 2022 |
||||||||||||||||||||
Number of Common Shares (‘000) |
Shares to be Issued |
Additional Paid- in-Capital |
Accumulated Deficit |
Total Shareholders’ Equity |
||||||||||||||||
Balance – June 30, 2022 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||
Share issuance - MPX purchase option |
( |
) | — | — | ||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance – September 30, 2022 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2022 |
||||||||||||||||||||
Number of Common Shares (‘000) |
Shares to be Issued |
Additional Paid- in-Capital |
Accumulated Deficit |
Total Shareholders’ (Deficit) Equity |
||||||||||||||||
Balance – January 1, 2022 - (Revised) |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
Share-based compensation | — | — | — | |||||||||||||||||
Share issuance - Recapitalization Transaction |
— | — | ||||||||||||||||||
Share issuance - MPX purchase option |
( |
) | — | — | ||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance – September 30, 2022 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2021 |
||||||||||||||||||||
Number of Common Shares (‘000) |
Shares to be Issued |
Additional Paid- in-Capital |
Accumulated Deficit |
Total Shareholders’ Equity |
||||||||||||||||
Balance – June 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance – September 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2021 |
||||||||||||||||||||
Number of Common Shares (‘000) |
Shares to be Issued |
Additional Paid- in-Capital |
Accumulated Deficit |
Total Shareholders’ Equity |
||||||||||||||||
Balance – January 1, 2021 - (Revised) |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance – September 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
||||||||
2022 |
2021 |
|||||||
CASH FLOW FROM OPERATING ACTIVITIES |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash (used in) provided by operations: |
||||||||
Interest income |
( |
) | ( |
) | ||||
Interest expense |
||||||||
Accretion expense |
||||||||
Debt obligation fees |
||||||||
Impairment loss |
||||||||
Depreciation and amortization |
||||||||
(Recoveries), write-downs and other charges, net |
( |
) | ||||||
Share-based compensation |
||||||||
Losses from change in fair value of financial instruments |
( |
) | ||||||
Gain from nonmonetary consideration from acquisition (Refer to Note 4) |
( |
) | — | |||||
Loss on debt extinguishment (Refer to Note 5) |
— | |||||||
Change in operating assets and liabilities (Refer to Note 13) |
||||||||
NET CASH FLOW (USED IN) PROVIDED BY OPERATING ACTIVITIES |
$ |
( |
) |
$ |
||||
CASH FLOW FROM INVESTING ACTIVITIES |
||||||||
Purchase of property, plant and equipment |
( |
) | ( |
) | ||||
Acquisition of other intangible assets |
( |
) | ( |
) | ||||
Proceeds from sale of property, plant and equipment |
— | |||||||
Issuance of related party promissory note |
( |
) | ( |
) | ||||
Purchase of subsidiaries, net of cash acquired |
— | |||||||
NET CASH USED IN INVESTING ACTIVITIES |
$ |
( |
) |
$ |
( |
) | ||
CASH FLOW FROM FINANCING ACTIVITIES |
||||||||
Proceeds from issuance of debt |
||||||||
Debt issuance costs |
( |
) | ||||||
Repayment of debt |
( |
) | ( |
) | ||||
NET CASH PROVIDED BY FINANCING ACTIVITIES |
$ |
$ |
||||||
CASH AND RESTRICTED CASH: |
||||||||
NET INCREASE IN CASH AND RESTRICTED CASH DURING THE PERIOD |
||||||||
CASH AND RESTRICTED CASH, BEGINNING OF PERIOD (Refer to Note 13) |
||||||||
CASH AND RESTRICTED CASH, END OF PERIOD (Refer to Note 13) |
$ |
$ |
||||||
Prior Year’s Line item |
Reclassified Amount |
Current Year’s Line item | ||||||||
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
|||||||||
Depreciation and amortization |
$ | $ | Selling, general and administrative expenses | |||||||
Depreciation and amortization |
( |
) | ( |
) | Depreciation and amortization |
December 31, 2021 |
||||||||||||
As previously reported |
Adjustment |
As adjusted |
||||||||||
Inventories |
$ | $ | ( |
) | $ | |||||||
Current assets |
( |
) | ||||||||||
Total assets |
( |
) | ||||||||||
Accrued and other current liabilities |
( |
) | ||||||||||
Current liabilities |
( |
) | ||||||||||
Total liabilities |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
Total shareholders’ deficit |
( |
) | ( |
) | ( |
) | ||||||
Total liabilities and shareholders’ deficit |
( |
) |
Year Ended December 31, 2021 |
||||||||||||
As previously reported |
Adjustment |
As adjusted |
||||||||||
Costs and expenses applicable to revenues |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Gross profit |
( |
) | ||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
Loss from operations before income tax |
( |
) | ( |
) | ( |
) | ||||||
Income tax expense |
( |
) | ||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Earnings per share |
( |
) | ( |
) | ( |
) |
September 30, 2022 |
||||||||||||
As reported |
Adjustment |
As adjusted |
||||||||||
Accumulated deficit – Balance January 1, 2022 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total s hareholders’ deficit – Balance January 1, 2022 |
( |
) | ( |
) | ( |
) |
Operating Leases |
||||
2023 |
$ | |||
2024 |
||||
2025 |
||||
2026 |
||||
2027 |
||||
Thereafter |
||||
|
|
|||
Total lease payments |
$ | |||
Less: interest expense |
( |
) | ||
|
|
|||
Present value of lease liabilities |
$ | |||
Weighted-average remaining lease term (years) |
||||
Weighted-average discount rate |
% | |||
|
|
Balance Sheet Information |
Classification |
September 30, 2022 |
December 31, 2021 |
|||||||
Right-of-use |
Operating leases |
$ | |
$ | |
|||||
Lease liabilities |
||||||||||
Current portion of lease liabilities |
Operating leases | $ | $ | |||||||
Long-term lease liabilities |
Operating leases | |||||||||
|
|
|
|
|||||||
Total |
$ |
$ |
||||||||
|
|
|
|
September 30, 2022 |
December 31, 2021 |
|||||||
(Revised) |
||||||||
Supplies |
$ | $ | ||||||
Raw materials |
||||||||
Work in process |
||||||||
Finished goods |
||||||||
|
|
|
|
|||||
Total |
$ |
$ |
||||||
|
|
|
|
Consideration |
||||
Cash |
$ | |||
Settlement of pre-existing relationships |
||||
|
|
|||
Fair value of consideration |
$ |
|||
|
|
|||
Assets acquired and liabilities assumed |
||||
Cash |
$ | |||
Fixed assets |
||||
Other non-current assets |
||||
Intangible assets |
||||
Accounts payable |
( |
) | ||
Accrued and other current liabilities |
( |
) | ||
|
|
|||
Net assets acquired |
$ |
|||
|
|
• | renegotiation of existing financing arrangements and other material contracts, including any amendments, waivers, extensions or similar agreements with the Lenders and/or stakeholders of the Company and/or its subsidiaries that the Special Committee determines are in the best interest of the Company and/or its subsidiaries; |
• | managing available sources of capital, including equity investments or debt financing or refinancing and the terms thereof; |
• | implementing the operational and financial restructuring of the Company and its subsidiaries and their respective businesses, assets and licensure and other rights; and |
• | implementing other potential strategic transactions. |
Secured Notes (1) |
March 2019 Debentures |
May 2019 Debentures |
June Secured Debentures |
Additional Secured Debentures |
June Unsecured Debentures |
Other |
Total |
|||||||||||||||||||||||||
As of January 1, 2022 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||
Fair value of financial liabilities issued |
— | — | — | |||||||||||||||||||||||||||||
Accretion of balance |
— | — | ||||||||||||||||||||||||||||||
Debt extinguishment |
( |
) | ( |
) | ( |
) | — | — | — | — | ( |
) | ||||||||||||||||||||
Repayment |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||
As of September 30, 2022 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
(1) | This amount includes the Company’s obligation to pay an exit fee of $ d interest at a rate of |
• | On June 24, 2022, an aggregate of |
• | On August 18, 2022, |
September 30, 2022 |
||||||||
Units |
Weighted Average Exercise Price (C$) |
|||||||
Warrants outstanding, beginning |
$ | |||||||
Granted |
||||||||
Forfeited |
( |
) | ||||||
Expired |
( |
) | ||||||
|
|
|
|
|||||
Warrants outstanding, ending |
$ | |||||||
|
|
|
|
September 30, 2022 |
December 31, 2021 |
|||||||
Risk-free interest rate |
% | |||||||
Expected dividend yield |
% | |||||||
Expected volatility |
% | |||||||
Expected life |
September 30, 2022 |
December 31, 2021 |
|||||||||||||||
Year of expiration |
Number Outstanding |
Weighted Average Exercise Price (C$) |
Number Outstanding |
Weighted Average Exercise Price (C$) |
||||||||||||
2022 |
||||||||||||||||
2023 |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Warrants outstanding |
$ | $ | |
|||||||||||||
|
|
|